1. 2294 Growth modulation index (GMI) to assess salvage chemotherapy benefit after FOLFIRINOX progression in metastatic pancreatic adenocarcinoma. (September 2015) Authors: Ducoulombier, A.; Quintin, J.; Desjardin, M.; Hautefeuille, V.; Desauw, C.; Parzy, A.; Bouche, O.; Chauffert, B.; Clisant, S.; El Hajbi, F.; Becouarn, Y.; Bennouna, J.; Hebbar, M.; Penel, N.; Adenis, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2376 Impact of the definition of time to event endpoint on randomized clinical trials results in oncology (datecan-2): an analysis of 9 pancreatic cancer trials. (September 2015) Authors: Pam, A.; Vernerey, D.; Baron, B.; Chauffert, B.; Louvet, C.; Wagener, J.; Levi, F.; Hans, S.; Trouilloud, I.; Jan, J.; Van Laethem, J.L.; Taieb, J.; Haustermans, K.; Dahan, L.; Dureux, M.; Lutz, M.; Bellera, C.; Gourgou, S.; Anota, A.; Bonnetain, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial. Issue 11 (16th April 2014) Authors: Boulin, M.; Hillon, P.; Cercueil, J. P.; Bonnetain, F.; Dabakuyo, S.; Minello, A.; Jouve, J. L.; Lepage, C.; Bardou, M.; Wendremaire, M.; Guerard, P.; Denys, A.; Grandvuillemin, A.; Chauffert, B.; Bedenne, L.; Guiu, B. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 11(2014) Page Start: 1301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Incidence and survival rates for adult malignant neuro-epithelial brain tumors in the Somme county (France): A retrospective, population-based study from 2003 to 2013. (March 2018) Authors: Bello Roufai, D.; Caillet, P.; Lapôtre-Ledoux, B.; Trecherel, E.; Bauchet, L.; Chauffert, B.; Ganry, O. Journal: Journal of cancer policy Issue: Volume 15(2018) Part A Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma. (January 2021) Authors: Biau, J.; Thivat, E.; Chautard, E.; Stefan, D.; Boone, M.; Chauffert, B.; Bourgne, C.; Richard, D.; Molnar, I.; Levesque, S.; Bellini, R.; Kwiatkowski, F.; Karayan-Tapon, L.; Verrelle, P.; Godfraind, C.; Durando, X. Journal: Radiotherapy and oncology Issue: Volume 154(2021) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗